Changes between Version 9 and Version 10 of Research/DesignStudy/SteeringGroup/2020-07-03


Ignore:
Timestamp:
Jul 3, 2020, 3:49:30 PM (4 years ago)
Author:
longkr
Comment:

--

Legend:

Unmodified
Added
Removed
Modified
  • Research/DesignStudy/SteeringGroup/2020-07-03

    v9 v10  
    8888----
    8989
    90 == Agenda ==
    91 
    92 1. [wiki:Research/DesignStudy/SteeringGroup/2020-06-05 Notes of last meeting and actions arising:]
    93  * **KL**: Set up series of meetings with leads at partner organisations to discuss preparation of R&D programme.
    94   * **Ongoing.**  Need to step up the priority of this activity as we prepare the EPSRC proposal.
    95  * **KL/CB**: Consider meeting between Imperial (and other) ion-accelerator experts with the relevant experts in CLF.
    96   * **Stands.** This meeting is necessary and, probably, should include Strathclyde and Belfast.
    97  * **KL/KK** to collaborate on the development for a proposal for such a meeting on the timescale of November 2020.
    98   * **Stands.** Agenda item.
    99  * **KL** Send out diary invitation straight away to get it into the diary.
    100   * **Done.**
    101 
    102 2. [raw-attachment:2020-07-03-Progress-update.pdf Update on progress]: KL \\
    103 
    104 3. Discussion of SG composition: KL/All
    105 
    106 4. [https://epsrc.ukri.org/funding/calls/second-call-for-transformative-healthcare-technologies-pre-announcement-and-engagement-event/ EPSRC Transformative Healthcare Technologies call]: KL/All
    107  * Dealing with feedback from our 2019 submission: \\
    108    "//Engagement with patients, clinicians and industry could have been strengthened//"
    109   - Patient engagement:
    110    - Actions taken to date;
    111    - Need for local action by partner;
    112    - Subsequent coordination
    113   - Clinician engagement:
    114    - Actions taken to date;
    115    - Need for local action by partner;
    116    - Subsequent coordination
    117   - Industrial engagement:
    118    - Actions taken to date;
    119    - Discussion of next steps
    120  * Slides to initiate discussion of:
    121   - Scope;
    122   - Initial discussion of work packages;
    123   - Stakeholders from whom we should be seeking support;
    124  * Next steps discussion
    125  
    126 5. Follow-up Discussion of dedicated advanced diagnostics and instrumentation for the //in vitro// and //in vivo// end stations: KL/all
    127 
    128 6. DONMs \\
    129  * 04 Sep 2020; 10:00 BST
    130 
    131 7. AoB \\
    132  
    133 ----